HOOK - HOOKIPA Pharma Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-95.21M

Cash

135.6M

Avg Qtr Burn

-6.388M

Short % of Float

0.61%

Insider Ownership

5.01%

Institutional Own.

40.58%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
HB-200 (TheraT® LCMV) + pembrolizumab Details Cancer, Human papillomavirus, Head and neck squamous cell carcinoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HB-202/HB-201 Details Cancer, Human papillomavirus	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HB-300 Details Cancer, Castration-resistant prostate cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HB-101 (VaxWave®) Details Cytomegalovirus, Infectious disease, Kidney transplantation	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.